These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15890937)

  • 21. Humoral immunity to immunodominant epitopes of Hepatitis C virus in individuals infected with genotypes 1a or 1b.
    Carlos MP; Yamamura Y; Vu Q; Conzen K; Anderson DE; Torres JV
    Clin Immunol; 2004 Apr; 111(1):22-7. PubMed ID: 15093548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C in northern Estonia.
    Tallo T; Lappalainen M; Tefanova V; Priimägi I
    Acta Virol; 2000; 44(3):175-8. PubMed ID: 11155361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection.
    Rushbrook SM; Ward SM; Unitt E; Vowler SL; Lucas M; Klenerman P; Alexander GJ
    J Virol; 2005 Jun; 79(12):7852-9. PubMed ID: 15919939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dendritic cell function during chronic hepatitis C virus and human immunodeficiency virus type 1 infection.
    Fan Z; Huang XL; Kalinski P; Young S; Rinaldo CR
    Clin Vaccine Immunol; 2007 Sep; 14(9):1127-37. PubMed ID: 17634507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blocking of monocyte-associated B7-H1 (CD274) enhances HCV-specific T cell immunity in chronic hepatitis C infection.
    Jeong HY; Lee YJ; Seo SK; Lee SW; Park SJ; Lee JN; Sohn HS; Yao S; Chen L; Choi I
    J Leukoc Biol; 2008 Mar; 83(3):755-64. PubMed ID: 18086898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C virus-specific reactivity of CD4+-lymphocytes in children born from HCV-infected women.
    Della Bella S; Riva A; Tanzi E; Nicola S; Amendola A; Vecchi L; Nebbia G; Longhi R; Zanetti AR; Villa ML
    J Hepatol; 2005 Sep; 43(3):394-402. PubMed ID: 16023248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of chronic hepatitis C virus genotypes among patients between 21 to 65 years old in Puerto Rico.
    Rodríguez-Pérez F; Suárez-Pérez E; Alvarez-Rohena M; Toro DH
    P R Health Sci J; 2004 Jun; 23(2 Suppl):49-56. PubMed ID: 16929587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence of CD4
    Lucas M; Deshpande P; James I; Rauch A; Pfafferott K; Gaylard E; Merani S; Plauzolles A; Lucas A; McDonnell W; Kalams S; Pilkinton M; Chastain C; Barnett L; Prosser A; Mallal S; Fitzmaurice K; Drummer H; Ansari MA; Pedergnana V; Barnes E; John M; Kelleher D; Klenerman P; Gaudieri S
    Sci Rep; 2018 May; 8(1):7224. PubMed ID: 29740042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in the epidemiology of hepatitis C infection in Germany: shift in the predominance of hepatitis C subtypes.
    Ross RS; Viazov S; Renzing-Köhler K; Roggendorf M
    J Med Virol; 2000 Feb; 60(2):122-5. PubMed ID: 10596009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus core protein triggers expansion and activation of CD4(+)CD25(+) regulatory T cells in chronic hepatitis C patients.
    Zhai N; Chi X; Li T; Song H; Li H; Jin X; Crispe IN; Su L; Niu J; Tu Z
    Cell Mol Immunol; 2015 Nov; 12(6):743-9. PubMed ID: 25531392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humans.
    Kelly C; Swadling L; Capone S; Brown A; Richardson R; Halliday J; von Delft A; Oo Y; Mutimer D; Kurioka A; Hartnell F; Collier J; Ammendola V; Del Sorbo M; Grazioli F; Esposito ML; Di Marco S; Siani L; Traboni C; Hill AV; Colloca S; Nicosia A; Cortese R; Folgori A; Klenerman P; Barnes E
    Hepatology; 2016 May; 63(5):1455-70. PubMed ID: 26474390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
    Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
    J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection.
    Chang KM; Thimme R; Melpolder JJ; Oldach D; Pemberton J; Moorhead-Loudis J; McHutchison JG; Alter HJ; Chisari FV
    Hepatology; 2001 Jan; 33(1):267-76. PubMed ID: 11124845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-reactivity and clinical impact of the antibody response to hepatitis C virus second envelope glycoprotein (E2).
    Hadlock KG; Gish R; Rowe J; Rajyaguru SS; Newsom M; Warford A; Foung SK
    J Med Virol; 2001 Sep; 65(1):23-9. PubMed ID: 11505439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification, molecular cloning, and analysis of full-length hepatitis C virus transmitted/founder genotypes 1, 3, and 4.
    Stoddard MB; Li H; Wang S; Saeed M; Andrus L; Ding W; Jiang X; Learn GH; von Schaewen M; Wen J; Goepfert PA; Hahn BH; Ploss A; Rice CM; Shaw GM
    mBio; 2015 Feb; 6(2):e02518. PubMed ID: 25714714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive mapping of antigen specific T cell responses in hepatitis C virus infected patients with or without spontaneous viral clearance.
    Zhang C; Hua R; Cui Y; Wang S; Yan H; Li D; Zhang Y; Tu Z; Hao P; Chen X; Zhong J; Niu J; Jin X
    PLoS One; 2017; 12(2):e0171217. PubMed ID: 28170421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection.
    Wong DK; Dudley DD; Afdhal NH; Dienstag J; Rice CM; Wang L; Houghton M; Walker BD; Koziel MJ
    J Immunol; 1998 Feb; 160(3):1479-88. PubMed ID: 9570570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection.
    Lehmann M; Meyer MF; Monazahian M; Tillmann HL; Manns MP; Wedemeyer H
    J Med Virol; 2004 Jul; 73(3):387-91. PubMed ID: 15170633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. gC1qR expression in chimpanzees with resolved and chronic infection: potential role of HCV core/gC1qR-mediated T cell suppression in the outcome of HCV infection.
    Yao ZQ; Shata MT; Tricoche N; Shan MM; Brotman B; Pfahler W; Hahn YS; Prince AM
    Virology; 2006 Mar; 346(2):324-37. PubMed ID: 16368125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees.
    Folgori A; Capone S; Ruggeri L; Meola A; Sporeno E; Ercole BB; Pezzanera M; Tafi R; Arcuri M; Fattori E; Lahm A; Luzzago A; Vitelli A; Colloca S; Cortese R; Nicosia A
    Nat Med; 2006 Feb; 12(2):190-7. PubMed ID: 16462801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.